NCT06665594

Effect of TXA on Reducing Bruising After Filler Injection

Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Wisconsin, Madison · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to look at the effect tranexamic acid (TXA) may have on reducing bruising, swelling, and pain after facial filler injection. The main question it aims to answer is: * Does the addition of TXA to hyaluronic acid (HA) reduce bruising, swelling, and tenderness after HA injection? Participants will receive the study medication along with the standard facial filler injection and complete surveys.

Detailed description

The overall purpose of this study is to evaluate the safety and efficacy of co-administration of TXA with HA in reducing swelling, bruising and pain after facial injection. Researchers will do this by comparing HA to HA+TXA in participants undergoing facial filler injections. Participants undergoing facial filler injections almost always have the same type of injection performed bilaterally in order to maintain symmetry. This provides a unique opportunity where participants can serve as their own controls. Therefore, researchers have designed this as a half face study. Participants will be injected with HA on half of their face and the other half of the face will be injected with HA+TXA. Researchers will then assess swelling, bruising, pain, and overall satisfaction using participant self-reported surveys, physician surveys, and review of medical records.

Conditions

• Facial Filler Injections
• Hyaluronic Acid
• Tranexamic Acid

Interventions

Type	Name	Description
PROCEDURE	Hyaluronic Acid (HA)	Injectable gel
DRUG	Tranexamic Acid (TXA)	Injection of TXA
DRUG	Saline (placebo)	Injection of saline

Timeline

• Start date: 2025-12-05
• Primary completion: 2026-11-01
• Completion: 2026-11-01
• First posted: 2024-10-30
• Last updated: 2026-02-03

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study